Today: 29 April 2026
Unilever stock price today: ULVR shares climb as defensive names hold up amid tariff jitters
21 January 2026
1 min read

Unilever stock price today: ULVR shares climb as defensive names hold up amid tariff jitters

London, Jan 21, 2026, 08:34 GMT — Regular session

  • Unilever shares climbed 1.4% in early London trading, defying a weaker European market
  • Trade and inflation news pushed investors into a “defensive” stance
  • Investors are gearing up for Unilever’s full-year earnings report due Feb. 12

Unilever PLC shares climbed 1.4%, hitting 4,842.5 pence by mid-morning in London, up from Tuesday’s close at 4,775 pence.

The move was significant as European stocks slipped once more amid renewed trade tensions, investors closely monitoring Davos for any clues. U.S. President Donald Trump had just raised the prospect of tariffs tied to Greenland.

Against this backdrop, steady consumer staples attracted inflows while sectors tied to the economy took a hit. UK consumer prices for December also exceeded forecasts, fueling more uncertainty around rate bets.

Unilever, known for brands like Dove and Hellmann’s, has seen volatile trading this month as investors juggle its growth potential with its reputation as a defensive stock and reliable dividend payer.

No new company statement came out Wednesday to clarify the early jump in the shares.

Some investors have taken cues from brokers. Berenberg analyst Fulvio Cazzol, on Jan. 19, reaffirmed a buy rating for the stock, setting a price target at 5,600 pence. “The stock [is] attractive,” he noted. MarketScreener

Unilever’s U.S.-listed ADRs climbed roughly 0.6% in after-hours trading, hitting $64.90. This marks a more stable move following yesterday’s session in New York.

The broader risk sentiment stayed turbulent. London shares took a steep dive Tuesday following Trump’s tariff warning, prompting investors to trim cyclical bets swiftly amid the headline noise.

The downside scenario is straightforward: if trade threats escalate into actual policy or inflation remains stubborn, markets could swiftly adjust growth and margins — even hitting “safe” staples that rely on stable volumes and tight input-cost management.

Unilever is set to release its Q4 and full-year 2025 results on Feb. 12. Traders will be eyeing the management commentary at the CAGNY conference a few days later, on Feb. 17.

Stock Market Today

  • Energean Shifts Investment Outlook with New Angola Deal and Updated Price Targets
    April 29, 2026, 1:31 PM EDT. Energean's central fair value estimate nudged from £9.24 to £9.30, reflecting analyst adjustments amid evolving risks. Berenberg reduced price targets by 75 GBp and 15 GBp, citing concerns over project execution and valuation. Jefferies downgraded Energean in February, signaling caution over its risk-reward balance. Notably, Energean secured the safe restart of its Power FPSO vessel, resuming production after a temporary suspension due to geopolitical tensions in early 2026. The company also agreed to acquire Chevron's interests in offshore Angola blocks for US$260 million plus contingent payments, aiming to boost output and reserves. Investors face execution and valuation risks but gain fresh growth impetus from the Angola acquisition, positioning Energean at a pivotal point for portfolio consideration.

Latest article

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
BAE Systems share price: fresh buyback filing hits tape before London open
Previous Story

BAE Systems share price: fresh buyback filing hits tape before London open

United Airlines stock pops in premarket after UAL lifts 2026 profit outlook — what investors watch next
Next Story

United Airlines stock pops in premarket after UAL lifts 2026 profit outlook — what investors watch next

Go toTop